Dual mitochondria targeting fluorescent F16–TPP analogues were designed and synthesized.
5BMFis a new fluorescent mitochondria-accumulating delocalized lipophilic cations [DLC] that boasts significantly increased anti-cancer effects and low toxicity in comparison to previous DLCs, addressing current hurdles in DLC clinical translation.